+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

MYD88

Catalog No Product Description CAS No. Purity Structural Formula
BP5160 41263-94-9 98% 2'-Fucosyllactose
BP1260
Schaftoside
Schaftoside is a C-glycosyl compound that is apigenin substituted by beta-D-glucopyranosyl and an alpha-L-arabinopyranosyl moieties at positions 6 and 8 via C-glycosidic linkages. It has a role as an antioxidant and an antinematodal drug. It is a C-glycosyl compound and a trihydroxyflavone. It is functionally related to an apigenin. Schaftoside has antioxidant activity, it also can inhibit phospholipase, lipoxygenase and cyclooxygenase, three pro-inflammatory enzymes.
51938-32-0 98% Schaftoside
BP0033
Inulicin
Inulicin is a terpene lactone.
33627-41-7 98% Inulicin
BP1384
Theaflavin
Theaflavin is a suitable natural inhibitor against influenza A (H1N1) neuraminidase, which has anti-inflammatory, antioxidative, anti-mutagenic, anti-HSV-1, and anti-carcinogenic properties. Theaflavin is active in the prevention of fatty liver and obesity, it can significantly reduce lipid accumulation, suppress fatty acid synthesis, and stimulate fatty acid oxidation. Theaflavin inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 expression in bone marrow-derived macrophages through the blockade of NF-κB and MAPK signaling pathways; it also protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Theaflavin is a biflavonoid that is 3,4,5-trihydroxybenzocyclohepten-6-one which is substituted at positions 1 and 8 by (2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl groups. It is the main red pigment in black tea. It has a role as an antioxidant, an antibacterial agent, a chelator, a radiation protective agent and a plant metabolite. It is a polyphenol and a biflavonoid.
4670-05-7 98% Theaflavin
BP2064
Dulcoside A
Dulcoside A is a sweetener and has antioxidant activity.
64432-06-0 98% Dulcoside A
BP1419
Tussilagone
Tussilagone has anti-cancer, anti-oxidant and anti-inflammatory activities. Tussilagone inhibits dendritic cell function through the induction of heme oxygenase-1; it has potential treatment of neuro-inflammatory diseases through the inhibition of overproduction of nitric oxide and prostaglandin E(2).
104012-37-5 98% Tussilagone
BP4267
Raffinose
After treatment with CVGI, Raffinose family oligosaccharide was hydrolyzed effectively to yield galactose and sucrose. AA-PCD resistance in Raffinose-grown cells occurs with a decrease in both ROS production and cytochrome c release as compared to glucose-grown cells en route to AA-PCD.
17629-30-0 98% Raffinose
BP5077 166338-14-3 98% Chikusaikoside II
BP5361
Momordin II
Highly purified Momordin II inhibits cell-free protein synthesis, releases adenine from rat liver ribosomes and from DNA, and has no RNase activity.
95851-41-5 98% Momordin II
SBP02433 160498-02-2 Bisandrographolide C
BP1100
Picroside II
Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities. It has potent anti-apoptotic activity against renal I/R injury by suppressing the TLR4/NF-κB signaling pathway, it can protect the ischemic kidney against renal fibrosis and improve the neurological function of rats upon cerebral ischemia reperfusion injury. Picroside II enhances nerve growth factor (NGF)-induced neurite outgrowth from PC12D cells by amplifying a down-stream step of MAP kinase in the NGF receptor-mediated intracellular MAP kinase-dependent signaling pathway.
39012-20-9 98% Picroside II
BP3993
Skullcapflavone II
Scullcapflavone II is a tetramethoxyflavone that is flavone substituted by methoxy groups at positions 6, 7, 8 and 6' and hydroxy groups at positons 5 and 2' respectively. It has a role as an anti-asthmatic drug, an EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor and a plant metabolite. It is a dihydroxyflavone and a tetramethoxyflavone. It is functionally related to a flavone. Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis, a widely used herbal medicine in anti-inflammatory and anticancer therapy in Korea. Skullcapflavone II may have therapeutic potential for the treatment of allergic asthma.
55084-08-7 98% Skullcapflavone II
BP0372
Ciwujianoside B
Ciwujianoside B can relieve fatigue, enhance memory, and improve human cognition, it may enhance reuse of choline to accelerate the synthesis of acetylcholine in hippocampal neurons by activation of cholinesterase. Ciwujianoside B has inhibitory effects on apoptosis induced by MIRI and cardiomyocytes apoptosis induced by H 2 O 2 in rats; it also shows radioprotective effects on the hematopoietic system in mice, which is associated with changes in the cell cycle, a reduction in DNA damage, and down-regulation of the ratio of Bax/Bcl-2 in bone marrow cells exposed to radiation.
114902-16-8 98% Ciwujianoside B
BP4944
Nardoaristolone B
Nardoaristolone B, a nor-sesquiterpenoid with an unusual fused ring system and having protective effects on the injury of neonatal rat cardiomyocytes. The novel mosquito-repellentsynthetic hydrindanesbased on noreremophilanes and nardoaristolone B which show increasedactivity against adult females of Aedes aegypti.
1422517-82-5 98% Nardoaristolone B
BP4531
Maltoheptaose
Maltoheptaose is a maltoheptaose heptasaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form.
34620-78-5 98% Maltoheptaose
BPF2268
Platyconic acid A
Platyconic acid A suppresses the development of respiratory inflammation, hyperresponsiveness, and remodeling by reducing allergic responses, and it may be a potential herbal drug for allergen-induced respiratory disease prevention. Platyconic acid A suppresses PMA-induced MUC5AC mRNA expression by inhibiting NF-κB activation via Akt in A549 cells. Platyconic acid A is a triterpenoid saponin. It has a role as a metabolite.
68051-23-0 98% Platyconic acid A
BP0492
Dihydroberberine
Dihydroberberine has anti-tumor activity. It also improves in vivo efficacy in terms of counteracting increased adiposity, tissue triglyceride accumulation, and insulin resistance in high-fat-fed rodents, thus is potential therapeutic reagents for type 2 diabetes treatment.
483-15-8 98% Dihydroberberine
SBP01371
Glucosyringic acid
Glucosyringic acid has immunosuppressive effect, it can inhibit the proliferation of murine B lymphocytes in vitro.
33228-65-8 98% Glucosyringic acid
BPF2740
Dehydroeburicoic acid
Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload, mitochondrial dysfunction, and calpain activation in human glioblastomas. Dehydroeburicoic acid and Eburicoic acid have antioxidant and anti-inflammatory activities by the decrease of inflammatory cytokines and an increase of antioxidant enzyme activity, can protect the liver from CCl4-induced hepatic damage.
6879-05-6 98% Dehydroeburicoic acid
BP5500 104121-82-6 98% 6''-O-acetyl-saikosaponin B2